tetano
Editor, Senior Moderator
Clin Vaccine Immunol. 2010 Jul 14. [Epub ahead of print]
Immunogenicity of the Routine Use of an Influenza A/H1N1 Vaccine in Health Care Personnel in Guangzhou, China.
Di B, Xu X, Li T, Lu E, Wu J, Liu Y, Chen Y, Pickerill S, Wang M.
Guangzhou Center for Disease Control and Prevention, Zhongshan Road 3,No.23, Guangzhou, 510080, P. R. China; Ustar Biotechnologies (Hangzhou) Co. Ltd., Hangzhou, Zhejiang 310012, P. R. China.
Abstract
We present immunogenicity data on the routine vaccination of 103 health care personnel during the 2009 H1N1 national vaccination campaign. Seroprotection (hemagglutination inhibition titer >/=1:40) was 83.2% at 30 days post-vaccination, lower than previously published controlled trials. Low baseline antibody levels, and an increase in seroprotection in a negative control cohort suggests that the virus remains prevalent.
PMID: 20631339 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/20631339
Immunogenicity of the Routine Use of an Influenza A/H1N1 Vaccine in Health Care Personnel in Guangzhou, China.
Di B, Xu X, Li T, Lu E, Wu J, Liu Y, Chen Y, Pickerill S, Wang M.
Guangzhou Center for Disease Control and Prevention, Zhongshan Road 3,No.23, Guangzhou, 510080, P. R. China; Ustar Biotechnologies (Hangzhou) Co. Ltd., Hangzhou, Zhejiang 310012, P. R. China.
Abstract
We present immunogenicity data on the routine vaccination of 103 health care personnel during the 2009 H1N1 national vaccination campaign. Seroprotection (hemagglutination inhibition titer >/=1:40) was 83.2% at 30 days post-vaccination, lower than previously published controlled trials. Low baseline antibody levels, and an increase in seroprotection in a negative control cohort suggests that the virus remains prevalent.
PMID: 20631339 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/20631339